Poddar Richa 4
4 · AGIOS PHARMACEUTICALS, INC. · Filed Oct 18, 2022
Insider Transaction Report
Form 4
Poddar Richa
Chief Commercial Officer
Transactions
- Exercise/Conversion
Common stock
2022-10-15+5,000→ 9,993 total - Exercise/Conversion
Restricted stock units
2022-10-15−5,000→ 0 total→ Common stock (5,000 underlying) - Tax Payment
Common stock
2022-10-17$27.48/sh−1,485$40,808→ 8,508 total
Footnotes (3)
- [F1]Includes 312 shares purchased through the Company's employee stock purchase plan.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- [F3]The restricted stock units were granted on October 15, 2020. The shares underlying the restricted stock units will vest in full on October 15, 2022.